These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16940766)

  • 1. Neuroprotective effects of modafinil in a marmoset Parkinson model: behavioral and neurochemical aspects.
    van Vliet SA; Vanwersch RA; Jongsma MJ; van der Gugten J; Olivier B; Philippens IH
    Behav Pharmacol; 2006 Sep; 17(5-6):453-62. PubMed ID: 16940766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the neuroprotective effects of modafinil in a marmoset Parkinson model with immunohistochemistry, magnetic resonance imaging and spectroscopy.
    van Vliet SA; Blezer EL; Jongsma MJ; Vanwersch RA; Olivier B; Philippens IH
    Brain Res; 2008 Jan; 1189():219-28. PubMed ID: 18076869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiparkinsonian and neuroprotective effects of modafinil in the mptp-treated common marmoset.
    Jenner P; Zeng BY; Smith LA; Pearce RK; Tel B; Chancharme L; Moachon G
    Exp Brain Res; 2000 Jul; 133(2):178-88. PubMed ID: 10968218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The vigilance-promoting drug modafinil counteracts the reduction of tyrosine hydroxylase immunoreactivity and of dopamine stores in nigrostriatal dopamine neurons in the male rat after a partial transection of the dopamine pathway.
    Ueki A; Rosén L; Andbjer B; Finnman UB; Altamimi U; Janson AM; Goldstein M; Agnati LF; Fuxe K
    Exp Brain Res; 1993; 93(2):259-70. PubMed ID: 8098283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Parkinson effects of a selective alpha2C-adrenoceptor antagonist in the MPTP marmoset model.
    Philippens IH; Joosen MJ; Ahnaou A; Andres I; Drinkenburg WP
    Behav Brain Res; 2014 Aug; 269():81-6. PubMed ID: 24769173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral effects of modafinil in marmoset monkeys.
    van Vliet SA; Jongsma MJ; Vanwersch RA; Olivier B; Philippens IH
    Psychopharmacology (Berl); 2006 May; 185(4):433-40. PubMed ID: 16550386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurobehavioral protection by single dose l-deprenyl against MPTP-induced parkinsonism in common marmosets.
    Ando K; Maeda J; Inaji M; Okauchi T; Obayashi S; Higuchi M; Suhara T; Tanioka Y
    Psychopharmacology (Berl); 2008 Jan; 195(4):509-16. PubMed ID: 17879087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
    Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
    Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effects of Delta9-THC and modafinil in a marmoset Parkinson model.
    van Vliet SA; Vanwersch RA; Jongsma MJ; Olivier B; Philippens IH
    Eur Neuropsychopharmacol; 2008 May; 18(5):383-9. PubMed ID: 18222654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective mechanism of modafinil on Parkinson disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Xiao YL; Fu JM; Dong Z; Yang JQ; Zeng FX; Zhu LX; He BC
    Acta Pharmacol Sin; 2004 Mar; 25(3):301-5. PubMed ID: 15000882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A stereological study on the neuroprotective actions of acute modafinil treatment on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigral lesions of the male black mouse.
    Aguirre JA; Cintra A; Hillion J; Narváez JA; Jansson A; Antonelli T; Ferraro L; Rambert FA; Fuxe K
    Neurosci Lett; 1999 Nov; 275(3):215-8. PubMed ID: 10580713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of caffeine and modafinil in counteracting sleep deprivation in the marmoset monkey.
    van Vliet SA; Jongsma MJ; Vanwersch RA; Olivier B; Philippens IH
    Psychopharmacology (Berl); 2008 Mar; 197(1):59-66. PubMed ID: 18057918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of bifemelane on parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset.
    Nomoto M; Irifune M; Fukuzaki K; Fukuda T
    Neurosci Lett; 1994 Aug; 178(1):95-8. PubMed ID: 7816348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effects of riluzole in early phase Parkinson's disease on clinically relevant parameters in the marmoset MPTP model.
    Verhave PS; Jongsma MJ; Van Den Berg RM; Vanwersch RA; Smit AB; Philippens IH
    Neuropharmacology; 2012 Mar; 62(4):1700-7. PubMed ID: 22178201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-DOPA-induced behavioral sensitization of motor activity in the MPTP-treated common marmoset as a Parkinson's disease model.
    Ando K; Inoue T; Itoh T
    Pharmacol Biochem Behav; 2014 Dec; 127():62-9. PubMed ID: 25449794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a protective action of the vigilance promoting drug modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis.
    Fuxe K; Janson AM; Rosén L; Finnman UB; Tanganelli S; Morari M; Goldstein M; Agnati LF
    Exp Brain Res; 1992; 88(1):117-30. PubMed ID: 1347270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
    Kupsch A; Sautter J; Götz ME; Breithaupt W; Schwarz J; Youdim MB; Riederer P; Gerlach M; Oertel WH
    J Neural Transm (Vienna); 2001; 108(8-9):985-1009. PubMed ID: 11716151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents.
    Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X
    Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of baseline locomotion and other behavioral traits in a common marmoset model of Parkinson's disease established by a single administration regimen of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: providing reference data for efficacious preclinical evaluations.
    Ando K; Inoue T; Hikishima K; Komaki Y; Kawai K; Inoue R; Nishime C; Nishinaka E; Urano K; Okano H
    Behav Pharmacol; 2020 Feb; 31(1):45-60. PubMed ID: 31625972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modafinil prevents the MPTP-induced increase in GABAA receptor binding in the internal globus pallidus of MPTP-treated common marmosets.
    Zeng BY; Smith LA; Pearce RK; Tel B; Chancharme L; Moachon G; Jenner P
    Neurosci Lett; 2004 Jan; 354(1):6-9. PubMed ID: 14698469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.